COVID treatments – where are we?

Dr Linda Calabresi

writer

Dr Linda Calabresi

GP; Medical Editor, Healthed

Dr Linda Calabresi

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

Firstly, it needs to be understood that ‘no proven effective therapies currently exist’, the review authors state. But despite this depressing reality, the upside is we already know a significant amount of detail about this novel coronavirus and its lifecycle in host cells, which provides scientists many potential targets for treatments. We also have the opportunity to review agents used in the past to treat SARS and MERS, which are similar viruses to COVID-19.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

References

JAMA published online April 13,2020. Doi 10:1001/jama2020.6019

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Kate Walsh

Dr Kate Walsh

Endometriosis Cases – Practical Guide

Prof Finlay Macrae AO

Prof Finlay Macrae AO

Familial Colorectal Cancer

Prof Richard Harvey

Prof Richard Harvey

Recurrent Nasal Polyps Management – When to Refer

Prof Terence O'Brien

Prof Terence O'Brien

SUDEP – What is it and How to Reduce the Risk

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

We invite you to join the upcoming Healthed webcast where Prof Macrae speak on how GPs can suspect, assess and manage hereditary colorectal cancer risk.

Tuesday 2nd September, 7pm AEST